Overall, the results indicated that the targeted IN-ABPs (HG92 and HG90) outperformed the non-targeted controls (HG31 and HG99, respectively) in terms of their ability to specifically detect cathepsin activity within tumor tissues. Here, CTSS is linked to neoplasm.